Comparative Study of Different Combinational Mucoadhesive Formulations of Sumatriptan-Metoclopramide
Author(s) -
Mitra Jelvehgari,
Hadi Valizadeh,
Sanam Ziapour,
Mahdieh Rahmani,
Seyed Hassan Montazam,
Saieede Soltani
Publication year - 2016
Publication title -
advanced pharmaceutical bulletin
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.773
H-Index - 35
eISSN - 2251-7308
pISSN - 2228-5881
DOI - 10.15171/apb.2016.018
Subject(s) - bioavailability , differential scanning calorimetry , chemistry , particle size , buccal administration , mannitol , chromatography , hydroxypropyl cellulose , dosage form , polymer , materials science , nuclear chemistry , chemical engineering , pharmacology , organic chemistry , medicine , physics , engineering , thermodynamics
Sumatriptan succinate (Sum) is a Serotonin 5- HT1 receptor agonist, used in the treatment of migraine. It is absorbed rapidly but incompletely when taken orally and underwent first - pass metabolism, resulting in a low bioavailability of about 15%. The aim was to design mucoadhesive buccal discs and sublingual films of Sum and metoclopramide (Met) combined to improve their bioavailability.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom